Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex. (Q39160757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Fatou Aw

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Isabelle Goyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Marie-Josée Raboisson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Christine Boutin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Philippe Major

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

23 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

394-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Genetics and molecular biology of tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

21 January 2018

Pediatric heart tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Natural history of cardiac rhabdomyoma in infancy and childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Incessant ventricular tachycardia due to multiple cardiac rhabdomyomas in an infant with Tuberous Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Left ventricular outflow obstruction in rhabdomyoma of infancy: meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Regression of a cardiac rhabdomyoma in a patient receiving everolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Primary cardiac tumours: when is surgery necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Sudden Death of a Young Child Due to Cardiac Rhabdomyoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-016-1528-Y

Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27878332

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rapid regression of left ventricular outflow tract rhabdomyoma after sirolimus therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27878332

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00246-016-1528-Y

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878332%20AND%20SRC:MED&resulttype=core&format=json